Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

Drugs

woman wearing yellow and pink floral dress wahing carrots

Prescribing Lecanemab in Real Life

July 28, 2023 1 Comment

Dr. Robert Przybelski has prescribed lecanemab to real-life patients, and discusses his experience prescribing and administering the treatment.

Lilly’s Donanemab: The 3rd New Alzheimer’s Drug

July 21, 2023 No Comments

Now, a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA),. The field of new drugs is beginning to show progress in the fight to slow the disease.

New Alzheimer’s Drug Lecanemab: High price tag, Moderate warnings

July 14, 2023 No Comments

The FDA has approved generic lecanemab (brand name Leqembi^®). The new drug can slow the progression of Alzheimer’s. Two top doctors discuss the pros and cons.

Leqembi Medication for Alzheimer's (Generic: Lecanemab)

Alzheimer’s Drug Leqembi Gets Full FDA and MEDICARE Approval

July 7, 2023 No Comments

First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.

FDA Unanimously Votes Leqembi Benefits Alzheimer’s

June 11, 2023 1 Comment

The FDA Advisory Committee’s endorsement of Leqembi paves way for traditional approval, ushers in a new era for Alzheimer’s

FDA Votes 9-1 to Advance Rexulti for Alzheimer’s

May 15, 2023 No Comments

The FDA has approved the supplemental New Drug Application (sNDA) of REXULTI® (brexpiprazole) for the treatment of agitation associated with Alzheimer’s. It’s the first such treatment to be approved in the US. Learn more.

woman in white coat holding black dslr camera

Next Alzheimer’s Drug? Donamebab Significantly Slows Cognitive Decline

May 3, 2023 No Comments

Eli Lilly Company’s TRAILBLAZER-ALZ 2 Phase 3 study shows that donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer’s disease. Learn more.

FDA Okays Trial of Alzheimer’s Pill with Unique Mechanism

January 25, 2023 No Comments

The new Alzheimer’s injections Aduhelm and Lecanemab offer hope. Now, Mastinimab is trying to break through to the next level with a simpler pill. Mastinimab fights Alzheimer’s via a revolutionary mechanism of action. Learn why the FDA approved Mastinimab’s final round of trials.

Lecanemab Enters Advanced Alzheimer’s Gene Trials

February 13, 2022 No Comments

VIDEO + ARTICLE: Phase II/III trials are begining in the Tau NextGen study. The study will assess the effect of Lecanemab, an experimental anti-amyloid therapy,

FDA-Approved Bumetanide Could Be Next Alzheimer’s Drug

November 8, 2021 No Comments

OLD-NEW DRUG RESEARCH: The diuretic bumetanide, used for more than 30 years to treat hypertension and heart failure, was also found to reverse signs of

Cynicism Triples Dementia Risk?

March 10, 2026

In a study on health & cynicism, people were asked how much they agree with statements such as, “I think most people would lie to get ahead,” and “It is safer to trust nobody”. The clear connection between their answers and their risk of dementia may startle you.

hands, holding, old, yeng, windows wallpaper, hd wallpaper, free wallpaper, desktop backgrounds, laptop wallpaper, care, background, mac wallpaper, wallpaper 4k, 4k wallpaper, free background, wallpaper hd, beautiful wallpaper, 4k wallpaper 1920x1080, cool backgrounds, people hand, full hd wallpaper, brown care

To Touch and Be Touched in Dementia

March 9, 2026

TEEPA SNOW: EXPLORE how touch has a profound impact on human connection in dementia care, with Teepa Snow, MS, OTR/L. Teepa shares why physical contact is vital and how there are different reactions to touch and need for touch. Discover the importance of understanding surprising reactions from people with dementia.

Rehydration for Dementia

March 9, 2026

Lewis Hornby had a problem: his grandmother with dementia wasn’t drinking enough, causing her to get severely dehydrated.

Most Popular Stories

12 Intervention Sessions Improve Cognition

Researchers say it takes a dozen “intervention sessions” to improve cognition in those at risk for Alzheimer’s and other dementias.

FDA-Approved Sargramostim Improves Alzheimer’s Cognition

FDA-approved Sargramostim, a normal human protein, improved memory and cognition in Alzheimer’s patients in a Phase II clinical trial. The drug is safe and well-tolerated, and has been used for other disorders for 30 years.

Son singing alongside father with dementia

Father with Dementia Belts Out “Quando Quando” with Son

This carpool sing-a-long between a father with dementia and his son went viral. $50,000 in donations poured into the Alzheimer’s Society. Enjoy their great music. Sing along if you can!